July 2023 FDA Recall Fosfomycin Tromethamine by Ascend Laboratories, Llc
D-1145-2023 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Ascend Laboratories, Llc on July 18, 2023 for the product Fosfomycin Tromethamine. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1145-2023

Reason for Recall
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Initiated
07-18-2023
Reported
09-13-2023
Quantity
99,516 sachets

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Ascend Laboratories, LLC
The recall product was distributed nationwide.
Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57

Batch or Lot Expiration Information

Lot# 22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024.

Affected Packages Involved in this Recall